Tyra Biosciences Inc
NASDAQ:TYRA
Balance Sheet
Balance Sheet Decomposition
Tyra Biosciences Inc
Tyra Biosciences Inc
Balance Sheet
Tyra Biosciences Inc
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
0
|
15
|
302
|
251
|
58
|
92
|
|
| Cash Equivalents |
0
|
15
|
302
|
251
|
58
|
92
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
145
|
249
|
|
| Other Current Assets |
0
|
0
|
2
|
6
|
8
|
6
|
|
| Total Current Assets |
0
|
15
|
304
|
257
|
212
|
347
|
|
| PP&E Net |
0
|
1
|
2
|
4
|
8
|
8
|
|
| PP&E Gross |
0
|
1
|
2
|
4
|
8
|
8
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
1
|
1
|
1
|
|
| Other Long-Term Assets |
0
|
0
|
1
|
5
|
6
|
8
|
|
| Total Assets |
1
N/A
|
16
+3 100%
|
307
+1 817%
|
266
-13%
|
226
-15%
|
364
+61%
|
|
| Liabilities | |||||||
| Accounts Payable |
0
|
1
|
1
|
1
|
5
|
1
|
|
| Accrued Liabilities |
1
|
1
|
3
|
5
|
11
|
14
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
4
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
5
|
2
|
4
|
6
|
15
|
15
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
1
|
3
|
6
|
6
|
|
| Total Liabilities |
5
N/A
|
2
-62%
|
5
+150%
|
8
+68%
|
22
+157%
|
20
-6%
|
|
| Equity | |||||||
| Common Stock |
0
|
28
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
5
|
14
|
40
|
96
|
165
|
251
|
|
| Additional Paid In Capital |
0
|
0
|
342
|
354
|
369
|
594
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
1
|
|
| Total Equity |
5
N/A
|
14
N/A
|
302
+2 055%
|
258
-15%
|
204
-21%
|
343
+68%
|
|
| Total Liabilities & Equity |
1
N/A
|
16
+3 100%
|
307
+1 817%
|
266
-13%
|
226
-15%
|
364
+61%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
39
|
39
|
41
|
42
|
43
|
51
|
|